Blood Pressure DEA Safety 
Cannabis Law Report
JUNE 28, 2021
Drug Enforcement Agency (“DEA”). While CBP has at least provided some response to the initial request, DEA has completely stonewalled the Initiative to date. While CBP has at least provided some response to the initial request, DEA has completely stonewalled the Initiative to date. Drug Enforcement Administration (DEA).
Cannabis Law Report
SEPTEMBER 23, 2019
Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health. The AAFP supports requirements testing current marijuana and cannabinoid products for safety, dosing, and product consistency. In the Exam Room.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
MAY 15, 2023
Ketamine has a long safety record as an anesthetic since the 1980s, and it has also been successfully used “off-label” for over a decade to treat conditions such as anxiety, depression, OCD, and PTSD, among others. Some programs may supply a blood-pressure cuff to check for high blood pressure, a common side effect of ketamine.
Cannabis Law Report
NOVEMBER 2, 2021
Testing for Safety: Are Impurities a Problem? Testing for Safety: Are Impurities a Problem? May affect blood pressure, heart rate, intraocular pressure. The second argument is based on a DEA interim final rule on the topic of synthetic THC. Table of Contents. Executive Summary. What We Discovered.
The Cannigma
SEPTEMBER 12, 2021
The safety of using these products however, is still unknown. Marijuana (defined in the US as any cannabis plant where THC>0.3%) is a schedule I drug according to the DEA and FDA. Research suggests that THC may be able to reduce blood pressure by activating the GPR18 receptor. Who discovered THC? THC and PPAR-gamma.
Expert insights. Personalized for you.
97 
Let's personalize your content